Corteva (NYSE:CTVA) Given New $89.00 Price Target at Royal Bank Of Canada

Corteva (NYSE:CTVA) had its price objective lifted by investment analysts at Royal Bank Of Canada from $80.00 to $89.00 in a report issued on Thursday, Marketbeat.com reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective would suggest a potential upside of 22.14% from the company’s current price.

CTVA has been the subject of a number of other research reports. Argus upgraded shares of Corteva to a “strong-buy” rating in a report on Friday, January 16th. Bank of America lifted their target price on Corteva from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Thursday, January 8th. BNP Paribas Exane raised their price objective on shares of Corteva from $70.00 to $72.00 and gave the company a “neutral” rating in a research note on Monday, November 17th. Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a research report on Thursday, January 22nd. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on Corteva from $90.00 to $85.00 and set a “buy” rating on the stock in a research report on Thursday, November 6th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $81.11.

Corteva Price Performance

Shares of Corteva stock traded down $2.25 on Thursday, hitting $72.87. The company’s stock had a trading volume of 931,482 shares, compared to its average volume of 3,876,970. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.07 and a current ratio of 1.58. The company has a market capitalization of $49.24 billion, a price-to-earnings ratio of 46.24, a price-to-earnings-growth ratio of 1.91 and a beta of 0.75. The firm has a fifty day moving average price of $68.60 and a 200-day moving average price of $68.40. Corteva has a 1 year low of $53.40 and a 1 year high of $77.41.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 8.97%. The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. During the same period in the prior year, the business posted $0.32 earnings per share. The firm’s revenue for the quarter was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts anticipate that Corteva will post 2.96 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Corteva

Hedge funds and other institutional investors have recently made changes to their positions in the company. Chilton Capital Management LLC boosted its position in Corteva by 18.1% during the third quarter. Chilton Capital Management LLC now owns 445,350 shares of the company’s stock valued at $30,119,000 after buying an additional 68,380 shares during the period. TriaGen Wealth Management LLC purchased a new stake in Corteva during the 3rd quarter valued at $4,284,000. New York State Teachers Retirement System increased its position in shares of Corteva by 4.5% in the third quarter. New York State Teachers Retirement System now owns 551,389 shares of the company’s stock valued at $37,290,000 after acquiring an additional 23,548 shares during the period. Truist Financial Corp boosted its holdings in shares of Corteva by 4.5% during the third quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock worth $21,771,000 after purchasing an additional 13,910 shares during the period. Finally, Nordea Investment Management AB increased its holdings in Corteva by 27.4% during the 3rd quarter. Nordea Investment Management AB now owns 75,675 shares of the company’s stock valued at $5,103,000 after purchasing an additional 16,261 shares during the period. 81.54% of the stock is owned by institutional investors.

Key Corteva News

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Management raised FY‑2026 EPS guidance to $3.45–$3.70, above the Street, signaling confidence in margin expansion and growth platforms. Strong 2H and Full Year 2025 Results Driven by Leading Technology, Disciplined Execution
• Positive Sentiment: Company highlighted record free cash flow and disciplined working‑capital management for FY‑2025, which supports buybacks/deployment and reduces execution risk. Corteva Inc (CTVA) Q4 2025 Earnings Call Highlights: Record Free Cash Flow and Strategic …
• Neutral Sentiment: Q4 EPS was $0.22 — roughly in line with consensus and slightly above one estimate — suggesting profitability held up despite revenue pressure. Corteva, Inc. (CTVA) Surpasses Q4 Earnings Estimates
• Neutral Sentiment: Analysts show mixed views on Corteva’s outlook and positioning in materials/agriculture — differing takes add to near‑term volume sensitivity but not a clear directional signal. Analysts Have Conflicting Sentiments on These Materials Companies: Corteva (CTVA) and Southern Copper (SCCO)
• Negative Sentiment: Q4 revenue missed materially: $3.91B vs. estimates near $4.23B; management cited seasonal timing shifts and weaker crop‑protection/seed demand, which pressured the headline and prompted after‑hours selling. Corteva misses quarterly sales estimates
• Negative Sentiment: After‑hours coverage noted a ~3% share drop tied to the seasonal timing/revenue miss, amplifying volatility into the session. Corteva shares fall 3% as seasonal timings shifts drive Q4 revenue miss
• Negative Sentiment: JPMorgan cut its rating from Overweight to Neutral (albeit with a slightly higher $77 PT), a downgrade that can weigh on near‑term sentiment among institutional holders. Benzinga: JPMorgan downgrades Corteva

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.